- €6.03bn
- €14.43bn
- €17.02bn
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,191 | 6,472 | 8,104 | 11,195 | 17,021 |
Cost of Revenue | |||||
Gross Profit | 5,185 | 4,448 | 6,228 | 7,779 | 11,550 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 6,409 | 5,856 | 7,275 | 9,861 | 15,769 |
Operating Profit | 782 | 616 | 829 | 1,334 | 1,252 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 545 | 508 | 575 | 869 | 820 |
Provision for Income Taxes | |||||
Net Income After Taxes | 398 | 411 | 404 | 615 | 622 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 352 | 380 | 332 | 441 | 542 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 352 | 380 | 332 | 441 | 542 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.34 | 4.31 | 5.21 | 7.87 | 10.1 |
Dividends per Share |